Navigation Links
Agenda set for upcoming global conference on stem cell therapy to be held Jan. 20-21, 2011
Date:1/5/2011

WHAT: The agenda for the Sixth International Conference on Cell Therapy for Cardiovascular Disease (IC3D) has been set and is available at http://celltherapy.crf.org/conference/agenda.html. The conference, which will be held January 20-21, 2011, is a one-and-a-half day comprehensive program dedicated to the evolving field of cell-based therapies for the repair and regeneration of cardiac and vascular disease, as well as related diseases such as diabetes and stroke. This year's conference will focus on commercialization aspects of the field, highlighting the status of molecular, cell, and tissue products in addition to delivery systems.

WHY: Now in its 10th year of clinical trials, the application of stem cells in the treatment of cardiovascular diseases has seen many notable successes, as well as identified challenges that await the next round of clinical studies. Leaders in the field will convene to present their work, experiences, observations, and opinions on the benefits and unmet challenges of cell-based therapies.

Sessions will focus on:

  • Autologous cell products
  • Allogenic cells, hybrid preparations, and specialty products
  • Molecular interventions: Macro and micro agents
  • Delivery methods and imaging
  • Selection of biologics and methodologies in the development of the next generation of clinical trials

WHO: Warren Sherman, MD, Course Director, is Director of Cardiac Cell-Based Endovascular Therapies at the Center for Interventional Vascular Therapy at NewYork-Presbyterian Hospital and Columbia University Medical Center. Dr. Sherman is a renowned clinical investigator in the field of myocardial regeneration who pioneered a technique for injecting stem cells into the heart. In Rotterdam in May 2001, he performed the first catheter-based injection of stem cells into the heart of a patient with congestive heart failure due to a previous heart attack. At Columbia University Medical Center, researchers led by Dr. Sherman are using the patient's own myoblasts -- progenitor cells found in muscle -- to repair and replace injured cardiac tissue in a process called myogenesis. Dr. Sherman collaborates in studies to improve the outcomes of cell implantation with colleagues at Columbia University Medical Center, all of whom will be presenting their research at the conference.

WHEN: January 20-21, 2011

WHERE: Vivian and Seymour Milstein Family Heart Center
Myrna L. Daniels Auditorium
NewYork-Presbyterian Hospital/Columbia University Medical Center
New York, NY

For more information visit: http://celltherapy.crf.org/

HOW TO REGISTER:

Media may apply for registration by emailing jromero@crf.org.


'/>"/>

Contact: Judy Romero
jromero@crf.org
Cardiovascular Research Foundation
Source:Eurekalert

Related medicine news :

1. Bersin & Associates Unveils Agenda for Research Conference, IMPACT 2010: The Business of Talent(R)
2. Scientific community to set research agenda for infection prevention and control for next decade
3. National Democratic Strategist Bob Weiner Discusses Healthcare, Political Aftermath, Obama Agenda in Radio Interview
4. Report proposes new research agenda on pregnancy intentions of HIV-positive women
5. Transformation at top of agenda for CPMRCs annual conference in Jan. 2011
6. Republicans Give Top Award to Betsy McCaughey, Healthcare Patriot, & Rev Up for Upcoming Elections
7. SOKO Fitness & Spa Group to Present at Upcoming Investor Conferences
8. Good Vibrations Announces Upcoming Donation Partner: Clitoraid
9. Marin Cosmetic Surgery Center "The Center of Excellence" Celebrating It's Upcoming Tenth Year Anniversary With Miguel A. Delgado, Jr., M.D.
10. Upcoming Simulcast to Teach Women How to Lose Weight and Naturally Balance Hormones with Polycystic Ovarian Syndrome
11. KidsPlay Unplugged, LLC Launches Website; Announces Production of Upcoming DVD's Encouraging Children to Engage in Free Spirited and Imaginary Play
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... (PRWEB) , ... May 27, 2016 , ... Southland ... line of classic American timber frame barn kits, which can be found on its ... inspired by historic American barn plans, and they highlight the craftsmanship of timber post ...
(Date:5/27/2016)... ... May 27, 2016 , ... With over 60 percent of acute stroke survivors ... sustainable product to aid in the rehabilitation process has steadily increased. Ekso Bionics had ... with hemiplegia due to stroke. , Ekso Bionics has now received clearance from the ...
(Date:5/27/2016)... ... May 27, 2016 , ... Beleza Medspa has initiated a new ... This is the first time that Coolsculpting is being used for for more than ... to ensure they meet the prescribed body-fat standard, measured by the circumference-based tape method. ...
(Date:5/27/2016)... ... May 27, 2016 , ... With a team of ... food industries. Aside from its GMP accreditation, Validation Center is also a registered ... products, services and staff. , Validation Center is ISO17025 accredited and only offers ...
(Date:5/26/2016)... ... May 26, 2016 , ... Cabot Corporation, Pfizer, and ... according to court documents and SEC filings. A jury has returned a ... American Optical Corporation, Case No. BC588866, Los Angeles County, California. The jury awarded ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... --   , Study met ... cleansing and superiority in , Excellent ... of the ascending colon   , ... Norgine B.V. today announced new positive data from the phase III ... versus standard 2 litre PEG with ascorbate. The study met both ...
(Date:5/24/2016)... Zealand , May 24, 2016 ... informatics solutions for the healthcare sector, has been named the ... Zealand Hi-Tech Awards 2016. Dr Bruce Davey ... acknowledgement for our team.  It,s really good to be recognised ... healthcare internationally. Our products are used in 35 countries around ...
(Date:5/24/2016)... , May 24, 2016 Celsion ... drug development company, today provided an update on ... escalating clinical trial combining GEN-1, the Company,s DNA-based ... treatment of newly-diagnosed patients with advanced ovarian cancer ... debulking surgery.  GEN-1 is an IL-12 DNA plasmid ...
Breaking Medicine Technology: